Michal Mik
Overview
Explore the profile of Michal Mik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mroczkowski P, Mik M
Lancet Gastroenterol Hepatol
. 2025 Mar;
10(4):288.
PMID: 40088902
No abstract available.
2.
Borycka K, Mlynczak M, Rosol M, Korzeniewski K, Iwanowski P, Herman H, et al.
Sci Rep
. 2025 Mar;
15(1):7522.
PMID: 40033085
To evaluate the clinical performance and safety of the ONIRY system for obstetric anal sphincter injuries (OASI) detection versus three-dimensional endoanal ultrasound (EAUS). A prospective, comparative, multicentre, international study. Poland,...
3.
Jannasch O, Schwanz M, Otto R, Mik M, Lippert H, Mroczkowski P
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941783
Background: Lymphadenectomy is a fundamental part of surgical strategy in patients with gastric cancer. Lymph node (LN) status is a key point in assessment of prognosis in gastric cancer. The...
4.
Przybyszewski O, Mik M, Nowicki M, Kusinski M, Mikolajczyk-Solinska M, Sliwinska A
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200178
Pancreatic cancer is a severe disease, challenging to diagnose and treat, and thereby characterized by a poor prognosis and a high mortality rate. Pancreatic ductal adenocarcinoma (PDAC) represents approximately 90%...
5.
Swiechowski R, Pietrzak J, Wosiak A, Mik M, Balcerczak E
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38891994
The PI3K/AKT pathway plays a pivotal role in cellular processes, and its dysregulation is implicated in various cancers, including colorectal cancer. The present study correlates the expression levels of critical...
6.
Siwinski P, Dziki L, Mik M, Dziki A
Pol Przegl Chir
. 2024 Feb;
96(1):27-33.
PMID: 38353092
<b><br>Introduction:</b> Recurrence of rectal cancer affects from 4% to even 50% of patients after surgical treatment. The incidence may be influenced by numerous factors depending on the patient, the characteristics...
7.
Kedzia-Berut R, Berut M, Wlodarczyk M, Wlodarczyk J, Dziki L, Dziki A, et al.
Pol Przegl Chir
. 2024 Feb;
96(0):41-45.
PMID: 38348978
<b><br>Introduction:</b> Colorectal cancer is becoming an increasingly significant health issue, being one of the more commonly diagnosed malignancies. Colorectal tumors account for 10% of all malignant cancers in women and...
8.
Kabzinski J, Gogolewska M, Nowakowski M, Kucharska E, Dziki L, Mik M, et al.
Pol Przegl Chir
. 2022 Apr;
94(2):54-59.
PMID: 35485310
<b>Introduction:</b> Colorectal cancer (CRC), despite intensive research on the improvement of diagnosis and treatment, is still the second most deadly cancer in Poland in terms of mortality. One of the...
9.
Association of GEMIN4 gene polymorphisms with the risk of colorectal cancer in the Polish population
Cieslak A, Galita G, Mik M, Dziki L, Dziki A, Sokolowski I, et al.
Pol Przegl Chir
. 2022 Apr;
93(0):40-45.
PMID: 35384865
<br><b>Aim:</b> Gem-associated protein 4 (GEMIN4), a member of the GEMIN gene family, is a key compound of the regulating factors responsible for miRNA biogenesis. Genetic variability within this gene can...
10.
Darnikowska J, Jedrzejczak B, Dziki A, Mik M
Pol Przegl Chir
. 2022 Apr;
93(0):1-6.
PMID: 35384857
<b>Introduction:</b> An important factor determining health-oriented behavior is the health locus of control (HLC). Patients with cancer differ in health practices and perception of the disease. <br/><b>Aim:</b> Assessment of the...